货号:A105779
同义名:
硫酸羟氯喹
/ HCQ sulfate; Hydroxychloroquine(sulfate)(CRM)
Hydroxychloroquine sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions. Also acts as an inhibitor of autophagy and toll-like receptor (TLR)7/9.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Autophagy ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SBI-0206965 |
+++
ULK1, IC50: 108 nM ULK2, IC50: 711 nM |
95% | |||||||||||||||||
Hydroxychloroquine sulfate | ✔ | 99% | |||||||||||||||||
Valproic acid sodium | ✔ | HDAC | 97% | ||||||||||||||||
PFK-015 |
++
PFKFB3, IC50: 207 nM |
99%+ | |||||||||||||||||
MRT68921 HCl |
++++
ULK1, IC50: 2.9 nM ULK2, IC50: 1.1 nM |
99%+ | |||||||||||||||||
ROC-325 | ✔ | 99%+ | |||||||||||||||||
Autophinib |
+++
Autophagy, IC50: 40 nM |
99% | |||||||||||||||||
Lys05 | ✔ | 99%+ | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | Hydroxychloroquine sulfate (HCQ sulfate) is a synthetic antimalarial agent that also inhibits Toll-like receptor 7/9 (TLR7/9) signaling. It is effective at inhibiting SARS-CoV-2 infection in vitro[1].[2].[3]. |
Animal study | Hydroxychloroquine sulfate is also prescribed for lupus treatment, and together with its analog chloroquine, it inhibits TLR7 and TLR9 signaling[2]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02603146 | Healthy Participants ... 展开 >> Rheumatoid Arthritis (RA) Prevention 收起 << | Phase 2 | Recruiting | March 2020 | - |
NCT01897116 | Melanoma | Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00430807 | Giant Cell Arteritis | Phase 3 | Completed | - | France ... 展开 >> Hospital Agen, France, 47923 Hospital Albi, France, 81000 Hospital Auch Auch, France, 32008 Hospital Avignon Avignon, France, 84902 University Hospital Besançon Besançon, France, 25030 Hospital Béziers Beziers, France, 34525 University Hospital Côte de Nacre Caen, France, 14033 University Hospital Dijon Dijon, France, 21035 Hospital Foix, France, 09017 Hospital Lavaur, France, 81500 University Hospital Dupuytren Limoges, France, 87042 Hospital Lisieux, France, 14100 Hospital Lourdes, France, 65107 Hospital Mazamet, France, 81200 Hospital Montauban, France, 82013 University Hospital Nantes, France, 44035 Saint Louis Hospital Paris, France, 75010 University Hospital Saint Antoine Paris, France, 75012 University Hospital Bichat Paris, France, 75018 Hospital Suresnes Suresnes, France, 92151 University Hospital Toulouse Toulouse, France, 31059 University Hospital Toulouse, France, 31059 University Hospital Bretonneau Tours, France, 37044 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.30mL 0.46mL 0.23mL |
11.52mL 2.30mL 1.15mL |
23.04mL 4.61mL 2.30mL |
CAS号 | 747-36-4 |
分子式 | C18H28ClN3O5S |
分子量 | 433.95 |
SMILES Code | CCN(CCO)CCCC(NC1=CC=NC2=CC(Cl)=CC=C12)C.O=S(O)(O)=O |
MDL No. | MFCD00078203 |
别名 | 硫酸羟氯喹 ;HCQ sulfate; Hydroxychloroquine(sulfate)(CRM); HCQ; NSC 4375; Hydroxychloroquine(sulfate); HCQ(sulfate) |
运输 | 蓝冰 |
InChI Key | JCBIVZZPXRZKTI-UHFFFAOYSA-N |
Pubchem ID | 12947 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Keep in dark place, inert atmosphere, room temperature |
溶解方案 |
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶。
|
动物实验配方 |
PO 0.5% CMC-Na 120 mg/mL clear |